Evaluation of a docetaxel-cisplatin-fluorouracil-Au complex in human oral carcinoma cell line
Source abstract
Abstract
Higher tobacco and alcohol use have led to a consistent increase in head and neck cancer incidence rates. Currently employed chemotherapeutic and surgical treatment are associated with significant drawbacks. Herein, we evaluated the anti-tumour effect of gold nanoparticles as a vehicle for the delivery of a triple chemotherapy drug formulation and elucidated the potential underlying mechanism. The hydrodynamic size of docetaxel, cisplatin, and 5-fluorouracil physically co-adsorbed on Au nanoparticles was 56 ± 0.8 nm, showing a negative zeta potential. Fourier transform infra-red spectroscopy data confirmed that the triple chemotherapy drug successfully interacted with the gold nano-carrier. Au nanoparticles exhibited high loading efficacy of docetaxel (61%), cisplatin (75%), and 5-fluorouracil (90%), with a controlled drug release profile at 24 h. The triple chemotherapy drug formulation was tested in human oral cavity cancer cell line (KB). Cytotoxicity achieved through a synergistic effect between the treatments led to apoptosis, with a lower half-maximal inhibitory concentration indicating higher cytotoxicity than that of plain docetaxel-cisplatin-fluorouracil. Taken together, we demonstrated that the docetaxel-cisplatin-fluorouracil-gold complex exhibited excellent cytotoxicity in KB cells, superior to that docetaxel-cisplatin-fluorouracil.HIGHLIGHTSThe docetaxel-cisplatin-fluorouracil-Au complex showed a controlled drug-release profile at 24 h.The docetaxel-cisplatin-fluorouracil-Au complex exhibited enhanced internalisation efficiency in cells.Au nanoparticles were biocompatible, with no change in apoptosis among cell line.Spherical Au nanoparticles allowed a high volume of incorporated docetaxel, cisplatin, and 5-fluorouracil to steadily attach onto cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Dendrimers and Hyperbranched Polymers · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Faculty of Medicine, King Mongkut’s Institute of Technology Ladkrabang, Bangkok, Thailand
Biomedical Physics Research Unit, Department of Physics, School of Science, King Mongkut’s Institute of Technology Ladkrabang, Bangkok, Thailand
Funding
King Mongkut’s Institute of Technology Ladkrabang
References (39)
Show source-provided references
1. Paul BF · 2021
2. Fatemeh A · J Dent Res Clin Dent Prospects · 2021 · 15 · 21910.34172/joddd.2021.036 ↗
3. Andreas EA · Mol Clin Oncol · 2017 · 7 · 15110.3892/mco.2017.1281 ↗
4. 10.1186/s12951-020-00604-710.1186/s12951-020-00604-7 ↗
5. Sindhu VG · Molecular Med Reports · 2015 · 12 · 302510.3892/mmr.2015.3768 ↗
6. Tae MY · Oncol Reports · 2017 · 37 · 366710.3892/or.2017.5584 ↗
7. Haddad RI · Ann Oncol · 2018 · 29 · 113010.1093/annonc/mdy102 ↗
8. Devale T · Front Oncol · 2020 · 10 · 128410.3389/fonc.2020.01284 ↗
9. Maureen B · BMC Cancer · 2021 · 21 · 36010.1186/s12885-021-08128-5 ↗
10. Jan BV. · 2021 · 155
11. Katsunori K · OTO Open · 2021 · 5 · 2473974X2110452
12. Nahid R · 2022
13. Yashwant VP · 2022
14. 10.3892/mmr.2020.1158010.3892/mmr.2020.11580 ↗
15. 10.2147/IJN.S25862510.2147/IJN.S258625 ↗
16. Vodyashkin AA · Chem Eng · 2021 · 5 · 69
17. Tomşa AM · Exp Ther Med · 2021 · 21 · 25810.3892/etm.2021.9689 ↗
18. Faid AH · BMC Chem · 2022 · 16 · 9010.1186/s13065-022-00889-9 ↗
19. 10.1515/ntrev-2022-047910.1515/ntrev-2022-0479 ↗
20. Yang Z · Front Oncol · 2022 · 11 · 81932910.3389/fonc.2021.819329 ↗
21. Alle M · J Nanobiotechnol · 2022 · 20 · 22210.1186/s12951-022-01402-z ↗
22. Archana SP · Turk J Pharm Sci · 2021 · 18 · 541
23. Fariba P · Pharm Sci · 2022 · 28 · 208
24. 10.1080/21691401.2019.167768110.1080/21691401.2019.1677681 ↗
25. 10.3389/fmolb.2020.58701210.3389/fmolb.2020.587012 ↗
26. 10.3390/biom1007097010.3390/biom10070970 ↗
27. Teruo H · J Comput Chem · 2020 · 41 · 197310.1002/jcc.26367 ↗
28. González-López MA · Cancer Nanotechnol · 2020 · 11 · 410.1186/s12645-020-00060-w ↗
29. Farhat J · Cryst Growth Des · 2020 · 20 · 240610.1021/acs.cgd.9b01570 ↗
30. Indiani CDV · J Nanoparticle Res · 2020 · 22 · 13310.1007/s11051-020-04839-1 ↗
31. Zembruski NC · Anal Biochem · 2012 · 429 · 7910.1016/j.ab.2012.07.005 ↗
32. 10.1016/j.molliq.2019.11166110.1016/j.molliq.2019.111661 ↗
33. Imamura Y · Med Oncol · 2021 · 38 · 12810.1007/s12032-021-01581-z ↗
34. Aarti M · Biomed Res Inter · 2014 · 2014 · 424239
35. Yuchen B · RSC Adv · 2018 · 8 · 3195010.1039/C8RA04512G ↗
36. Roghayyeh VG · Sci Reports · 2020 · 10 · 5569
37. Huan Y · RSC Adv · 2022 · 12 · 3253410.1039/D2RA03718A ↗
38. Ahmed K · ACS Biometer Sci Eng · 2021 · 7 · 254810.1021/acsbiomaterials.1c00339 ↗
39. National Center for Biotechnology Information. National Library of Medicine. KB cells. [cited 2023 Feb 21]. https://www.ncbi.nlm.nih.gov/mesh/?term=KB+Cells.